Downloads: 120 | Views: 254
Research Paper | Economics & Management | China | Volume 8 Issue 9, September 2019 | Popularity: 6.2 / 10
The Influence of Executive Shareholding in Pharmaceutical Industry on Corporate Performance from the Perspective of R&D
Zhao Fei
Abstract: This paper takes 138 pharmaceutical manufacturing listed companies in 2008-2018 as researchsamples, proposes hypotheses and establishes multiple regression models for empirical research, and explores the impact of executive shareholding ratio on firm performance, and between executives' holdings and R & D investment. The relationship between R & D expenditure as an intermediary variable between equity incentives and firm performance, explores the impact of executive shareholdings on firm performance through R & D investment, and provides a reference for pharmaceutical manufacturing listed companies to improve performance and maximize value.
Keywords: Executive shareholding, R&D investment, company performance
Edition: Volume 8 Issue 9, September 2019
Pages: 1170 - 1174
Make Sure to Disable the Pop-Up Blocker of Web Browser